# Artal Group S.A.: Form 13F holdings

An institutional investment manager in LUXEMBOURG. SEC CIK 1053906.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $931.1m
- Positions: 2 (2 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1053906/000105390626000008/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Cava Group Inc (CAVA)](/companies/cava.md) | COM | $510.7m | 54.9% | 6,507,990 |  | Reduced −3,000,000 |
| [Lexicon Pharmaceuticals Inc (LXRX)](/companies/lxrx.md) | COM NEW | $420.4m | 45.1% | 175,156,062 |  | Added +20,421,735 |

Source: SEC EDGAR, Form 13F-HR, accession 0001053906-26-000008. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.